Cooperberg MR, Broering JM, Carroll PR. Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis. JNCI Journal of the National Cancer Institute. 2009;101(12):878-887. doi:10.1093/jnci/djp122.

Zhao KH, et al. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Urology, 2008. 72(2): p. 396-400.

May M, et al. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. J Urol, 2007. 178(5): p. 1957-62; discussion 1962.

Cooperberg MR, et al. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer, 2006. 107(10): p. 2384-91.

Cooperberg MR, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol, 2005. 173(6): p. 1938-42.

Dr. Matthew R. Cooperberg

UCSF-CAPRA Score for Prostate Cancer Risk

gleason

stage

biopsy

<p>Predicts outcomes of patients post-treatment for prostate cancer.</p>

<p>Post-treatment outcomes for prostate cancer.</p>

UCSF-CAPRA Score

The UCSF-CAPRA (Cancer of the Prostate Risk Assessment) Score predicts outcomes of patients post-treatment for prostate cancer.

Gleason Score

D'Amico Classification

Manchester Score for Lung Cancer

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function